$ELOX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Eloxx Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eloxx Pharmaceuticals, Inc. for free.

Page:   1 2 3 4 5 ... 6 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 20 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BOption ExerciseA1.483,3344,9343,334
May 20 2021ELOXEloxx Pharmaceutic ...Kariv TomerOption ExerciseA1.4820,00029,60020,000
May 20 2021ELOXEloxx Pharmaceutic ...Seehra JasbirOption ExerciseA1.4820,00029,60020,000
May 18 2021ELOXEloxx Pharmaceutic ...MODUR VIJAYHEAD OF R&DOption ExerciseA1.41496,204699,648496,204
May 17 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BDirectorBuyP1.352,381,8903,215,5524,827,1292.4 M to 4.8 M (+97.41 %)
May 17 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BDirectorBuyP1.3584,776114,448171,80787 K to 171.8 K (+97.41 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.35592,592799,999616,59224 K to 616.6 K (+2,469.13 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.351,422,2221,920,0001,989,551567.3 K to 2 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.352,630,4873,551,1573,679,7971 M to 3.7 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP1.351,280,6241,728,8421,791,470510.8 K to 1.8 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.35592,592799,999616,59224 K to 616.6 K (+2,469.13 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.351,422,2221,920,0001,989,551567.3 K to 2 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.352,630,4873,551,1573,679,7971 M to 3.7 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP1.351,280,6241,728,8421,791,470510.8 K to 1.8 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP1.35592,592799,999616,59224 K to 616.6 K (+2,469.13 %)
May 17 2021ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP1.351,422,2221,920,0001,989,551567.3 K to 2 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP1.352,630,4873,551,1573,679,7971 M to 3.7 M (+250.69 %)
May 17 2021ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP1.351,280,6241,728,8421,791,470510.8 K to 1.8 M (+250.69 %)
May 03 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseM0.001,562010,938
May 03 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Payment of ExerciseF2.184591,00127,18027.6 K to 27.2 K (-1.66 %)
May 03 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...BuyM0.001,562027,63926.1 K to 27.6 K (+5.99 %)
Apr 22 2021ELOXEloxx Pharmaceutic ...Geffken Daniel E.CHIEF FINANCIAL OFF ...Option ExerciseA2.38100,000238,000100,000
Apr 05 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BOption ExerciseA3.3640,000134,40040,000
Apr 05 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BGrantA0.002,445,23902,445,2390 to 2.4 M
Apr 05 2021ELOXEloxx Pharmaceutic ...PAREKH RAJESH BGrantA0.0087,031087,0310 to 87 K
Apr 02 2021ELOXEloxx Pharmaceutic ...Walts Alan EdmundOption ExerciseA3.3640,000134,40040,000
Apr 02 2021ELOXEloxx Pharmaceutic ...Walts Alan EdmundOption ExerciseA0.0037,695037,695
Apr 02 2021ELOXEloxx Pharmaceutic ...MODUR VIJAYHEAD OF R&DOption ExerciseA3.36711,6192,391,040711,619
Apr 02 2021ELOXEloxx Pharmaceutic ...MODUR VIJAYHEAD OF R&DOption ExerciseA0.0044,6830219,326
Apr 02 2021ELOXEloxx Pharmaceutic ...MODUR VIJAYHEAD OF R&DOption ExerciseA0.00174,6430174,643
Apr 02 2021ELOXEloxx Pharmaceutic ...Aggarwal SumitPRESIDENT AND CEOOption ExerciseA3.361,423,2384,782,0801,423,238
Apr 02 2021ELOXEloxx Pharmaceutic ...Aggarwal SumitPRESIDENT AND CEOOption ExerciseA0.0055,8540279,158
Apr 02 2021ELOXEloxx Pharmaceutic ...Aggarwal SumitPRESIDENT AND CEOOption ExerciseA0.00223,3040223,304
Feb 26 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseM0.0025,000075,000
Feb 26 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Payment of ExerciseF3.957,33828,98526,07733.4 K to 26.1 K (-21.96 %)
Feb 26 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...BuyM0.0025,000033,4158.4 K to 33.4 K (+297.09 %)
Feb 26 2021ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Option ExerciseM0.0050,0000150,000
Feb 26 2021ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Payment of ExerciseF3.9515,36060,67244,62960 K to 44.6 K (-25.60 %)
Feb 26 2021ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...BuyM0.0050,000059,98910 K to 60 K (+500.55 %)
Feb 02 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseM0.001,563012,500
Feb 02 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Payment of ExerciseF3.445421,8648,4159 K to 8.4 K (-6.05 %)
Feb 02 2021ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...BuyM0.001,56308,9577.4 K to 9 K (+21.14 %)
Nov 02 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Option ExerciseM0.001,875016,875
Nov 02 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Payment of ExerciseF2.536251,5818,7579.4 K to 8.8 K (-6.66 %)
Nov 02 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...BuyM0.001,87509,3827.5 K to 9.4 K (+24.98 %)
Nov 02 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseM0.001,562014,063
Nov 02 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Payment of ExerciseF2.534591,1617,3947.9 K to 7.4 K (-5.84 %)
Nov 02 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...BuyM0.001,56207,8536.3 K to 7.9 K (+24.83 %)
Jul 31 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseM0.001,563015,625
Jul 31 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Payment of ExerciseF2.844591,3046,2916.8 K to 6.3 K (-6.80 %)
Jul 31 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...BuyM0.001,56306,7505.2 K to 6.8 K (+30.13 %)
Jul 31 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Option ExerciseM0.001,875018,750
Jul 31 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Payment of ExerciseF2.845761,6367,5078.1 K to 7.5 K (-7.13 %)
Jul 31 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...BuyM0.001,87508,0836.2 K to 8.1 K (+30.20 %)
May 26 2020ELOXEloxx Pharmaceutic ...Rubin Steven DOption ExerciseA3.3920,00067,80020,000
May 22 2020ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...Option ExerciseA3.3920,00067,80020,000
May 22 2020ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...Option ExerciseA3.3920,00067,80020,000
May 01 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Option ExerciseM0.001,875020,625
May 01 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Payment of ExerciseF2.925771,6856,2086.8 K to 6.2 K (-8.50 %)
May 01 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...BuyM0.001,87506,7854.9 K to 6.8 K (+38.19 %)
May 01 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseM0.001,562017,188
May 01 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Payment of ExerciseF2.924591,3405,1875.6 K to 5.2 K (-8.13 %)
May 01 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...BuyM0.001,56205,6464.1 K to 5.6 K (+38.25 %)
Mar 16 2020ELOXEloxx Pharmaceutic ...WEAVER GREGORY LOption ExerciseM0.003,75000
Mar 16 2020ELOXEloxx Pharmaceutic ...WEAVER GREGORY LPayment of ExerciseF2.851,0863,09510,43111.5 K to 10.4 K (-9.43 %)
Mar 16 2020ELOXEloxx Pharmaceutic ...WEAVER GREGORY LBuyM0.003,750011,5177.8 K to 11.5 K (+48.28 %)
Feb 26 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Option ExerciseA0.00200,0000200,000
Feb 26 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF EXECUTIVE OFF ...Option ExerciseA3.59400,0001,436,000400,000
Feb 26 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseA0.00100,0000100,000
Feb 26 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.COO, GENERAL COUNSE ...Option ExerciseA3.59200,000718,000200,000
Jan 31 2020ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...Option ExerciseM0.005,000015,000
Jan 31 2020ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...Payment of ExerciseF3.911,7336,7767,7679.5 K to 7.8 K (-18.24 %)
Jan 31 2020ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...BuyM0.005,00009,5004.5 K to 9.5 K (+111.11 %)
Jan 31 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Option ExerciseM0.007,500022,500
Jan 31 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Payment of ExerciseF3.912,59010,1274,9107.5 K to 4.9 K (-34.53 %)
Jan 31 2020ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...BuyM0.007,50007,5000 to 7.5 K
Jan 31 2020ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Option ExerciseM0.006,250018,750
Jan 31 2020ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Payment of ExerciseF3.912,0457,9964,2056.3 K to 4.2 K (-32.72 %)
Jan 31 2020ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...BuyM0.006,25006,2500 to 6.3 K
Jan 31 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Option ExerciseM0.006,250018,750
Jan 31 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Payment of ExerciseF3.912,1668,4694,0846.3 K to 4.1 K (-34.66 %)
Jan 31 2020ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...BuyM0.006,25006,2500 to 6.3 K
Dec 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHAIRMAN AND CEOOption ExerciseM0.0035,5990284,794
Dec 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHAIRMAN AND CEOPayment of ExerciseF7.2615,806114,752190,746206.6 K to 190.7 K (-7.65 %)
Dec 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHAIRMAN AND CEOBuyM0.0035,5990206,552171 K to 206.6 K (+20.82 %)
Sep 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHAIRMAN AND CEOOption ExerciseM0.0035,5990320,393
Sep 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHAIRMAN AND CEOPayment of ExerciseF4.3710,46745,741170,953181.4 K to 171 K (-5.77 %)
Sep 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHAIRMAN AND CEOBuyM0.0035,5990181,420145.8 K to 181.4 K (+24.41 %)
Sep 13 2019ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Option ExerciseA6.47150,000970,500150,000
Sep 13 2019ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Option ExerciseA6.47100,000647,000100,000
Sep 13 2019ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Option ExerciseA6.47225,0001,455,750225,000
Jun 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseM0.0035,5990355,992
Jun 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Payment of ExerciseF9.0310,46794,517145,821156.3 K to 145.8 K (-6.70 %)
Jun 27 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...BuyM0.0035,5990156,288120.7 K to 156.3 K (+29.50 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP9.0024,000216,00024,0000 to 24 K
Jun 26 2019ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP9.0046,933422,397567,329520.4 K to 567.3 K (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP9.0086,806781,2541,049,310962.5 K to 1 M (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorBuyP9.0042,261380,349510,846468.6 K to 510.8 K (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP9.0024,000216,00024,0000 to 24 K
Jun 26 2019ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP9.0046,933422,397567,329520.4 K to 567.3 K (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP9.0086,806781,2541,049,310962.5 K to 1 M (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Kariv TomerDirectorBuyP9.0042,261380,349510,846468.6 K to 510.8 K (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP9.0024,000216,00024,0000 to 24 K
Jun 26 2019ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP9.0046,933422,397567,329520.4 K to 567.3 K (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP9.0086,806781,2541,049,310962.5 K to 1 M (+9.02 %)
Jun 26 2019ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerBuyP9.0042,261380,349510,846468.6 K to 510.8 K (+9.02 %)
May 30 2019ELOXEloxx Pharmaceutic ...Kleijwegt MartijnOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Noiman SilviaOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Nussbaum RanOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Avnur ZafriraOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...Option ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...Option ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Kariv TomerOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Rubin Steven DOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Seehra JasbirOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Veinrib GadiOption ExerciseA9.0220,000180,40020,000
May 29 2019ELOXEloxx Pharmaceutic ...Noiman SilviaOption ExerciseA9.0220,000180,40020,000
Mar 28 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseM0.0035,5990391,591
Mar 28 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Payment of ExerciseF11.5010,467120,371120,689131.2 K to 120.7 K (-7.98 %)
Mar 28 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...BuyM0.0035,5990131,15695.6 K to 131.2 K (+37.25 %)
Jan 31 2019ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Option ExerciseA0.0025,000025,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Option ExerciseA11.5355,000634,15055,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Option ExerciseA0.0025,000025,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Option ExerciseA11.5350,000576,50050,000
Jan 31 2019ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...Option ExerciseA0.0020,000020,000
Jan 31 2019ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...Option ExerciseA11.5360,000691,80060,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseA11.53226,0002,605,780226,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Option ExerciseA0.0030,000030,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Option ExerciseA11.53100,0001,153,000100,000
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseM0.00213,5950427,190
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...GiftG0.0050,000095,557145.6 K to 95.6 K (-34.35 %)
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Payment of ExerciseF12.6083,0381,046,279145,557228.6 K to 145.6 K (-36.33 %)
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...BuyM0.00213,5950228,59515 K to 228.6 K (+1,423.97 %)
Jun 29 2018ELOXEloxx Pharmaceutic ...Noiman SilviaChief Executive Off ...Option ExerciseM0.00349,4002100
Jun 29 2018ELOXEloxx Pharmaceutic ...Noiman SilviaChief Executive Off ...BuyM0.00349,400210490,789141.4 K to 490.8 K (+247.12 %)
Jun 26 2018ELOXEloxx Pharmaceutic ...Williams Gregory C.Chief Operating Off ...Option ExerciseA18.84300,0005,652,000300,000
Jun 26 2018ELOXEloxx Pharmaceutic ...Snow David P.Chief Business Offi ...Option ExerciseA18.85200,0003,770,000200,000
Jun 26 2018ELOXEloxx Pharmaceutic ...Williams Gregory C.Chief Operating Off ...Option ExerciseA18.84300,0005,652,000300,000
Jun 26 2018ELOXEloxx Pharmaceutic ...Snow David P.Chief Business Offi ...Option ExerciseA18.85200,0003,770,000200,000
Jun 20 2018ELOXEloxx Pharmaceutic ...Belloff Neil S.General Counsel and ...Option ExerciseA20.85125,0002,606,250125,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Veinrib GadiDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Seehra JasbirDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Rubin Steven DDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Pontifax Management III G.P. ( ...10% OwnerOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Pontifax Management III G.P. ( ...10% OwnerOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Pontifax Management 4 G.P. (20 ...10% OwnerOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Nussbaum RanDirectorOption ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Noiman SilviaChief Executive Off ...Option ExerciseA23.2740,000930,80040,000
Jun 19 2018ELOXEloxx Pharmaceutic ...Noiman SilviaChief Executive Off ...Option ExerciseA23.27141,3893,290,122141,389

Page:   1 2 3 4 5 ... 6 next >

Contact us | Follow us on Twitter